Elon Musk just Triggered a BOOM in These Stocks Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk.

Click here to sign up for our free report & newsletter

Nicholas Michael Westfall net worth and biography

Nicholas Westfall Biography and Net Worth

EVP of Chemed

Nicholas M. Westfallis Executive Vice President of Chemed Corporation (NYSE:CHE). He is also Chief Executive Officer and Chief Operating Officer of the Company’s VITAS Healthcare Corporation subsidiary.

Mr. Westfall joined Chemed in 2009 as Director of Information Technology and Operations. He joined VITAS in 2012 as Senior Vice President of Field Operations and was promoted to Chief Operating Officer in 2015. In June 2016 the Chemed Board of Directors elected Mr. Westfall an Executive Vice President of the Company and he was also promoted to Chief Executive Officer of VITAS.

Prior to joining Chemed, he was a Senior Manager at Deloitte and Touche LLP, responsible for providing consulting services to clients primarily in healthcare, manufacturing, telecommunications and professional services industries.

Mr. Westfall holds a bachelor’s degree in chemical engineering from the University of Dayton in Ohio and a Master of Business Administration from the University of Michigan’s Ross School of Business.

What is Nicholas Michael Westfall's net worth?: The estimated net worth of Nicholas Michael Westfall is at least $3.83 million as of May 30th, 2023. Mr. Westfall owns 6,346 shares of Chemed stock worth more than $3,834,063 as of April 18th. This net worth estimate does not reflect any other investments that Mr. Westfall may own. Additionally, Mr. Westfall receives an annual salary of $2,500,000.00 as EVP at Chemed. Learn More about Nicholas Michael Westfall's net worth.
How old is Nicholas Michael Westfall?: Mr. Westfall is currently 45 years old. There are 5 older executives and no younger executives at Chemed. The oldest executive at Chemed is Mr. Thomas C. Hutton, VP & Director, who is 73 years old. Learn More on Nicholas Michael Westfall's age.
What is Nicholas Michael Westfall's salary?: As the EVP of Chemed Co., Mr. Westfall earns $2,500,000.00 per year. The highest earning executive at Chemed is Mr. Kevin J. McNamara, CEO, President & Director, who commands a salary of $5,840,000.00 per year. Learn More on Nicholas Michael Westfall's salary.
How do I contact Nicholas Michael Westfall?: The corporate mailing address for Mr. Westfall and other Chemed executives is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. Chemed can also be reached via phone at (513) 762-6690. Learn More on Nicholas Michael Westfall's contact information.
Has Nicholas Michael Westfall been buying or selling shares of Chemed?: Nicholas Michael Westfall has not been actively trading shares of Chemed in the last ninety days. Most recently, Nicholas Michael Westfall sold 1,330 shares of the business's stock in a transaction on Tuesday, May 30th. The shares were sold at an average price of $540.34, for a transaction totalling $718,652.20. Following the completion of the sale, the executive vice president now directly owns 6,346 shares of the company's stock, valued at $3,428,997.64. Learn More on Nicholas Michael Westfall's trading history.
Who are Chemed's active insiders?: Chemed's insider roster includes Patrick Grace (Director), Spencer Lee (EVP), Kevin McNamara (CEO), Thomas Rice (Director), Donald Saunders (Director), Nicholas Westfall (EVP), David Williams (CFO), and Michael Witzeman (VP). Learn More on Chemed's active insiders.
Are insiders buying or selling shares of Chemed?: During the last twelve months, insiders at the sold shares 14 times. They sold a total of 48,963 shares worth more than $28,922,374.69. The most recent insider tranaction occured on March, 28th when EVP Spencer S Lee sold 2,000 shares worth more than $1,283,300.00. Insiders at Chemed own 4.0% of the company. Learn More about insider trades at Chemed.
Information on this page was last updated on 3/28/2024.

Nicholas Michael Westfall Insider Trading History at Chemed

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/30/2023	Sell	1,330	$540.34	$718,652.20	6,346
5/10/2022	Sell	1,432	$500.10	$716,143.20	7,000
6/8/2021	Sell	2,708	$485.04	$1,313,488.32	999
12/11/2018	Sell	5,709	$301.75	$1,722,690.75	16,052
5/2/2018	Sell	10,643	$312.50	$3,325,937.50	7,191
11/13/2017	Sell	10,000	$231.00	$2,310,000.00	13,351

Nicholas Michael Westfall Buying and Selling Activity at Chemed

Chemed Company Overview

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Today's Range

Now: $604.17

$602.89

$611.80

50 Day Range

MA: $621.69

$571.74

$650.70

2 Week Range

Now: $604.17

$492.84

$654.62

Volume

66,645 shs

Average Volume

58,510 shs

Market Capitalization

$9.14 billion

P/E Ratio

33.71

Dividend Yield

0.26%

Beta

0.42

Top 5 Tech Stocks to Buy for 2024

From Daily Market Alerts | Ad

Elon Musk just Triggered a BOOM in These Stocks Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk.

Click here to sign up for our free report & newsletter

Nicholas Westfall Biography and Net Worth

What is Nicholas Michael Westfall's net worth?

How old is Nicholas Michael Westfall?

What is Nicholas Michael Westfall's salary?

How do I contact Nicholas Michael Westfall?

Has Nicholas Michael Westfall been buying or selling shares of Chemed?

Who are Chemed's active insiders?

Are insiders buying or selling shares of Chemed?